|1.||Cabado, Ana G: 1 article (05/2013)|
|2.||Blanco, Lucía: 1 article (05/2013)|
|3.||Vieites, Juan M: 1 article (05/2013)|
|4.||Ferreira, Martiña: 1 article (05/2013)|
|5.||Garrido, Alejandro: 1 article (05/2013)|
|6.||Miyagawa-Tomita, Sachiko: 1 article (08/2004)|
|7.||Ishihara, Yoko: 1 article (08/2004)|
|8.||Hagiwara, Hiromi: 1 article (08/2004)|
|9.||Tsukamoto, Yu: 1 article (08/2004)|
05/01/2013 - "The toxic effects of the organotin compounds (OTCs) monobutyltin (MBT), dibutyltin (DBT), and tributyltin (TBT) were evaluated in vitro in a neuroblastoma human cell line. "
05/01/2013 - "In vitro approaches to evaluate toxicity induced by organotin compounds tributyltin (TBT), dibutyltin (DBT), and monobutyltin (MBT) in neuroblastoma cells."
|2.||Body Weight (Weight, Body)
01/01/1988 - "The log dose-effect relationships for both compounds were linear and ran parallel over a dose range of 5-60 mg/kg. Dose levels calculated to cause 50% reduction of relative thymus weight were 18 mg DBTC and 29 mg TBTC per kg body wt. A single oral dose of mono-n-butyltin trichloride (MBTC), however, did not cause thymus atrophy at dose levels up to 180 mg/kg. The kinetics of the dibutyltin- and tributyltin-induced thymus atrophy in rats were investigated by measuring thymus weight, total thymic cell count, number of small, intermediate and large cells and the incorporation of DNA, RNA and protein precursors into isolated thymocytes during a period of 9 days after a single oral dose. "
|3.||RNA (Ribonucleic Acid)
|6.||DNA (Deoxyribonucleic Acid)